Revumenib Products | Cleanchem - Revumenib is an investigational drug being studied for the treatment of acute myeloid leukemia (AML). It works by targeting specific mutations in cancer cells, aiming to inhibit their growth and promote cell death. Clinical trials are ongoing to assess its safety and efficacy as a treatment option for AML.

Revumenib

Cat. No: CL-RVMB-01

CAS No: 2169919-21-3

Mol. F: C32H47FN6O4S

Mol. Wt: 630.8

Inv. Status: Custom Synthesis

Revumenib Impurity 1

Cat. No: CL-RVMB-02

CAS No: 2169923-02-6

Mol. F: C16H18FN3O2

Mol. Wt: 303.3

Inv. Status: Custom Synthesis

Revumenib Impurity 2

Cat. No: CL-RVMB-03

CAS No: 2169923-04-8

Mol. F: C16H17ClFN3O2

Mol. Wt: 337.8

Inv. Status: Custom Synthesis

Revumenib Impurity 3

Cat. No: CL-RVMB-04

CAS No: 2169923-03-7

Mol. F: C16H18FN3O3

Mol. Wt: 319.3

Inv. Status: Custom Synthesis

Revumenib Impurity 4

Cat. No: CL-RVMB-05

CAS No: 2169922-99-8

Mol. F: C28H38FN5O4

Mol. Wt: 527.6

Inv. Status: Custom Synthesis

Revumenib Impurity 5

Cat. No: CL-RVMB-06

CAS No: 2169920-33-4

Mol. F: C16H25NO5S2

Mol. Wt: 375.5

Inv. Status: Custom Synthesis

Revumenib Impurity 6

Cat. No: CL-RVMB-07

CAS No: 2169920-32-3

Mol. F: C9H19NO3S

Mol. Wt: 221.3

Inv. Status: Custom Synthesis

Revumenib Impurity 7

Cat. No: CL-RVMB-08

CAS No: 2169920-31-2

Mol. F: C10H19NO4S

Mol. Wt: 249.3

Inv. Status: Custom Synthesis

Revumenib Impurity 8

Cat. No: CL-RVMB-09

CAS No: 1549490-65-4

Mol. F: C12H16FNO2

Mol. Wt: 225.3

Inv. Status: Custom Synthesis

Revumenib Impurity 9

Cat. No: CL-RVMB-10

CAS No: 1023301-84-9

Mol. F: C12H22N2O2 : HCl

Mol. Wt: 226.3 : 36.5

Inv. Status: Custom Synthesis

Revumenib Impurity 10

Cat. No: CL-RVMB-11

CAS No: NA

Mol. F: C28H33FN4O4

Mol. Wt: 508.6

Inv. Status: Custom Synthesis